ESTRO 36 Programme book and exhibition guide

RADIOBIOLOGY PRE-MEETING COURSE

Clinical application of biomarkers: how to discover, explore, and validate biomarkers for normal tissue toxicity and tumour response FRIDAY 5 MAY 2017 08:45-17:00 | LEHAR 4 Course directors: J. Alsner (DK) and MC. Vozenin (CH)

Course aim Enable participants to understand the scientific and clinical aspects associated with discovery, exploration, and validation of biomarkers for personalised/precision radiation oncology (PRO) and raise awareness of key challenges in this important field.

Learning objectives • To understand the basic principles of prognostic and predictive biomarkers • To become familiar with biomarkers for normal tissue toxicity • To become familiar with biomarkers for tumour response • To appreciate the need for imaging and molecular biomarkers for PRO • To understand the principles for validation of biomarkers • To become familiar with legal and patent aspects for the clinical use of biomarkers. Who should attend? • Radiation oncologists, particularly those in the early stage of their career, who are keen to understand how biomarkers are important for PRO • Radiation biologists seeking information on how to maximise the clinical impact of their scientific discoveries • Radiation physicists and RTTs looking for an overview and update of recent and ongoing developments in the field of biomarkers.

Programme 08:45-09:00

Introduction and overview J. Alsner (DK)

Prognostic and predictive biomarkers J. Alsner (DK)

09:00-09:30

PROGRAMME | Programme and Exhibition Guide

58